These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27801583)

  • 1. Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles.
    Nieddu V; Pinna G; Marchesi I; Sanna L; Asproni B; Pinna GA; Bagella L; Murineddu G
    J Med Chem; 2016 Dec; 59(23):10451-10469. PubMed ID: 27801583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
    Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
    Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity.
    Zoroddu S; Corona P; Sanna L; Borghi F; Bordoni V; Asproni B; Pinna GA; Bagella L; Murineddu G
    Eur J Med Chem; 2022 Aug; 238():114440. PubMed ID: 35576700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
    Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
    Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
    Kumar D; Patel G; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
    Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV
    Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
    Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
    Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety.
    Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
    Eur J Med Chem; 2015 Jan; 90():45-52. PubMed ID: 25461310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA; Nour MS; Salem MA; Arafa RK
    Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents.
    Gurupadaswamy HD; Girish V; Kavitha CV; Raghavan SC; Khanum SA
    Eur J Med Chem; 2013 May; 63():536-43. PubMed ID: 23535322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization.
    Kamal A; Shaik AB; Polepalli S; Reddy VS; Kumar GB; Gupta S; Krishna KV; Nagabhushana A; Mishra RK; Jain N
    Org Biomol Chem; 2014 Oct; 12(40):7993-8007. PubMed ID: 25181296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers.
    Ewies EF; El-Hussieny M; El-Sayed NF; Fouad MA
    Eur J Med Chem; 2019 Oct; 180():310-320. PubMed ID: 31323616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolyl-α-keto-1,3,4-oxadiazoles: Synthesis, anti-cell proliferation activity, and inhibition of tubulin polymerization.
    Tantak MP; Malik M; Klingler L; Olson Z; Kumar A; Sadana R; Kumar D
    Bioorg Med Chem Lett; 2021 Apr; 37():127842. PubMed ID: 33556575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
    Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
    Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.
    Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK
    Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
    Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of 3,4-diaryl-1,2,5-oxadiazole-2/5-oxides as highly potent inhibitors of tubulin polymerization.
    Hong Y; Zhao Y; Yang L; Gao M; Li L; Man S; Wang Z; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
    Eur J Med Chem; 2019 Sep; 178():287-296. PubMed ID: 31195170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Screening of 5-Aryl-3-(2-(pyrrolyl)thiophenyl)-1,2,4-oxadiazoles as Potential Antitumor Molecules on Breast Cancer MCF-7 Cell Line.
    Abd El Hameid MK
    Chem Pharm Bull (Tokyo); 2018 Dec; 66(12):1181-1195. PubMed ID: 30298827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
    Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety.
    Ragab FAF; Abou-Seri SM; Abdel-Aziz SA; Alfayomy AM; Aboelmagd M
    Eur J Med Chem; 2017 Sep; 138():140-151. PubMed ID: 28667871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.